天然产物研究与开发 ›› 2023, Vol. 35 ›› Issue (11): 1907-1914.doi: 10.16333/j.1001-6880.2023.11.009

• 研究简报 • 上一篇    下一篇

HS-SPME-GC-MS分析柴胡、白芍配伍前后挥发性组分变化规律

张心一,江汉美,成   立,刘毅*   

  1. 湖北中医药大学药学院 湖北省药用植物研发中心,武汉430070
  • 出版日期:2023-11-28 发布日期:2023-11-25
  • 基金资助:
    国家自然科学基金(81772491);湖北省技术创新专项(重大项目)(2016ACA146)

HS-SPME-GC-MS analysis of the changes in volatile components before and after the compatibility of Radix Bupleurum and Radix Paeoniae Alba

ZHANG Xin-yi,JIANG Han-mei,CHENG Li,LIU Yi*   

  1. Hubei Research and Development Center of Medicinal Plants,College of Pharmacy,Hubei University of Traditional Chinese Medicine,Wuhan 430070,China
  • Online:2023-11-28 Published:2023-11-25

摘要: 为了探讨柴胡-白芍药对配伍的意义,通过单因素考察确定最佳萃取条件,采用顶空固相微萃取法(HS-SPME)与气相色谱-质谱(GC-MS)联用,测定柴胡、白芍及其药对挥发性成分,通过面积归一法确定各成分百分含量,并进行主成分分析(PCA)。结果表明:柴胡、白芍及其药对共有的挥发性成分有11种,但共有成分的含量有所不同。三者的PCA综合得分具有明显的差异,药对挥发性成分的PCA综合得分最高。柴胡-白芍药对的挥发性成分大部分来自于柴胡,柴胡、白芍配伍后有新的活性成分产生,从挥发性角度分析,柴胡、白芍配伍后具有一定增效减毒作用。

关键词: 柴胡, 白芍, 药对, 顶空固相微萃取, PCA, 增效减毒

Abstract:

In order to investigate the significance of the pairing of Radix Bupleurum (RB) and Radix Paeoniae Alba (RP),the optimal extraction conditions were determined by single-factor investigation,and the volatile components of RB,RP and RB-RP were determined by headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography-mass spectrometry (GC-MS),and the percentage content of each component was determined by area normalization and subjected to principal component analysis (PCA).The results showed that there were ten volatile components shared by RB,RP and RB-RP,but the contents of the shared components were different.The PCA scores of the three pairs were significantly different,with the highest PCA score for the volatile components of the pair.Most of the volatile components of the pair of RB-RP came from RB,and the combination of RB-RP produced new active ingredients,and from the volatility point of view,the combination of RB-RP has certain potency and toxicity reduction effects.

Key words: Radix Bupleurum, Radix Paeoniae Alba, drug pairs, headspace solid-phase microextraction, PCA, efficacy enhancing and toxicity reducing

中图分类号:  R284.1